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Summary
A number of recent linkage studies have suggested the
presence of a schizophrenia susceptibility locus on chro-
mosome 6p. We evaluated 28 genetic markers, spanning
chromosome 6, for linkage to schizophrenia in 10 mod-
erately large Canadian families of Celtic ancestry. Par-
ametric analyses of these families under autosomal dom-
inant and recessive models, using broad and narrow
definitions of schizophrenia, produced no significant ev-
idence for linkage. A sib-pair analysis using categorical
disease definitions also failed to produce significant ev-
idence for linkage. We then conducted a separate sib-
pair analysis using scores on positive-symptom (psy-
chotic), negative-symptom (deficit), and general psycho-
pathology–symptom scales as quan-
titative traits. With the positive symptom–scale scores,
the marker D6S1960 produced under5P  1.2# 10
two-point and under multipoint anal-6P  5.4# 10
yses. Using simulation studies, we determined that these
nominal P values correspond to empirical P values of
.034 and .0085, respectively. These results suggest that
a schizophrenia susceptibility locus on chromosome 6p
may be related to the severity of psychotic symptoms.
Assessment of behavioral quantitative traits may provide
increased power over categorical phenotype assignment
for detection of linkage in complex psychiatric disorders.
Introduction
Schizophrenia is a serious neuropsychiatric illness af-
fecting as much as 1% of the general population. Family,
twin, and adoption studies have demonstrated that
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schizophrenia is predominantly genetically determined
and has high heritability (Gottesman and Shields 1982;
Kendler and Diehl 1993; McGuffin et al. 1994). Al-
though no gene for schizophrenia has yet been identified,
evidence suggestive of linkage to chromosome 6p
(Straub et al. 1995; Wang et al. 1995), with supportive
evidence from other groups (Moises et al. 1995; Schwab
et al. 1995;Wang et al. 1996), has recently been achieved
by use of both parametric and nonparametric methods.
Together, these studies meet criteria for significant link-
age (Lander and Kruglyak 1995). The positive results
extend over a 40-cM region, with the strongest signals
from two or more studies occurring at 6p23 (markers
D6S274 and D6S285 [Moises et al. 1995; Schwab et al.
1995; Straub et al. 1995]) and with weaker results oc-
curring at 6p21 (markers CAR and D6S291 [Moises et
al. 1995; Schwab et al. 1995], closer to the HLA region.
Other studies, using similar methods, produced negative
or nonsignificant LOD scores (Antonarakis et al. 1995;
Gurling et al. 1995; Mowry et al. 1995), possibly be-
cause of low statistical power.
The studies showing positive linkage to 6p used large
samples of families from several geographic regions: 265
families from Ireland (Straub et al. 1995), 65 from Ger-
many and Israel (Schwab et al. 1995), 5 from Iceland,
and 65 from eight other countries (Moises et al. 1995).
Diagnostic categories varied fromnarrow (schizophrenia
and schizoaffective disorder [Moises et al. 1995; Schwab
et al. 1995; Straub et al. 1995]) to very broad (Straub
et al. 1995), including nonaffective psychotic disorders;
schizotypal, paranoid, schizoid, and avoidant person-
ality disorders; and affective psychotic disorders. Each
of these disorders may be genetically related to schizo-
phrenia (Kendler and Diehl 1993). Despite the use of a
broad phenotype and large sample sizes, LOD scores in
each of these studies were generally low, the largest being
3.51 (Straub et al. 1995), perhaps because of non-Men-
delian inheritance, genetic heterogeneity, and/or genes
that may be necessary but not sufficient to cause illness
(Matthysse et al. 1992; Tsuang 1993; Farmer et al. 1994;
Rutter 1994).
One way to increase power in linkage studies of com-
plex disorders, regardless of the mode of inheritance, is
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to use phenotypes that include key dimensions of gene
expression that may act as quantitative traits (Risch
1990; Matthysse et al. 1992; Faraone et al. 1995). Pos-
itive symptoms (disorganized thinking, hallucinations,
and delusions) and negative symptoms (blunted affect,
limited spontaneous speech, and social withdrawal) are
fundamental components of schizophrenia (Andreasen
et al. 1994). They are measurable in families and appear
to be related to genetic predisposition to schizophrenia
(Dworkin et al. 1991; McGuffin et al. 1991; Tsuang et
al. 1991; Bassett et al. 1993), which suggests that they
may be used as quantitative traits. In general patient
samples, longitudinal studies indicate that these symp-
tom clusters are stable during remission phases of schizo-
phrenic illness over periods of 1–10 years (Malla et al.
1993; Rey et al. 1994; Arndt et al. 1995; Eaton et al.
1995). In previous studies, we have shown that these
traits are measurable in familial schizophrenia in both
affected and unaffected individuals, using a sensitive as-
sessment instrument with good psychometric properties
(Bassett et al. 1993). On the basis of the hypotheses that
(1) different aspects of the schizophrenia phenotypemay
be primarily influenced by different genes and (2) non-
schizophrenic carriers of a schizophrenia susceptibility
allele may express symptom levels intermediate between
those of individuals with schizophrenia and those of
noncarriers, we have sought to apply a multidimen-
sional, quantitative scale to phenotype assignment in our
study of familial schizophrenia. We have therefore used
both diagnostic classification and quantitative-trait
measures to investigate linkage to markers on chro-
mosome 6 in 10 Canadian families of Celtic descent.
Subjects and Methods
Families and Phenotype Assignments
Canadian families of Celtic decent were recruited for
the linkage study if schizophrenic illness appeared to be
segregating in a unilineal autosomal dominant manner
(Bassett et al. 1993; Bassett and Honer 1994). Ten mod-
erately large families ( subjects) were assessedn  183
and had DNA samples available for the current study.
These subjects were all enrolled in this study after they
had given informed consent, and all procedures con-
formed to human-subjects protocols approved by the
University of Toronto and Rutgers University. Direct in-
terviews using the Structured Clinical Interview for
DSM-III-R (SCID) for major disorders, SCID-II for per-
sonality disorders, collateral information, and medical
records were used to make consensus diagnoses on the
basis of DSM-III-R criteria. Further details of the di-
agnostic and ascertainmentmethods have been described
elsewhere (Bassett et al. 1993; Bassett and Honer 1994).
The following diagnostic categories were used: narrow
(schizophrenia and chronic schizoaffective disorder),
broad (narrow plus nonaffective psychotic disorders and
schizotypal personality disorder), and very broad,
matching the Straub et al. (1995) D1–D8 classification
(broad plus psychotic affective disorders and paranoid,
avoidant, and schizoid personality disorder). There were
42, 65, and 70 affected individuals in the narrow, broad,
and very broad diagnostic categories, respectively.
A previous investigation had indicated that measures
of positive and negative symptomsmay be more sensitive
to genetic risk than is diagnostic classification (Bassett
et al. 1993). The Positive and Negative Syndrome Scale
(PANSS) (Kay 1987) is a 30-item scale with sound psy-
chometric properties designed to assess core signs and
symptoms of schizophrenia, on a severity continuum
from absent to extreme; the PANSS provides measures
of 7 positive symptom–scale items related to psychosis
and thought disorder (e.g., suspiciousness and disorgan-
ized thinking), 7 negative symptom–scale items related
to deficits in affect and behavior (e.g., blunted affect and
social withdrawal), and 16 general psychopathology
(GP) items related to general severity of illness (e.g., anx-
iety and somatic concerns). PANSS ratings were per-
formed by a psychiatrist when subjects were in a stable,
nonacute illness state, usually at the time of diagnostic
interview. Individual items were summed to give total
scores for the positive-symptom, negative-symptom, and
GP scales. PANSS data were available on 166 subjects.
Five of these subjects were excluded because the cross-
sectional PANSS assessments were confounded by the
presence of other, irreversible neuropsychiatric disorders
such as stroke and dementia, resulting in a sample of
161 subjects with usable PANSS scores. Figure 1 illus-
trates the distribution of the scores of this sample, for
affected and unaffected subjects, using the narrow di-
agnostic classification.
Genotyping
DNA was extracted from blood samples or lympho-
blastoid cell lines by use of the GenePure system (Gentra
Systems). DNA from each subject was genotyped by use
of the 23 chromosome 6 markers of the Weber V6
screening set (Research Genetics), as well as by use of 5
additional chromosome 6p markers (D6S296, D6S277,
D6S470, D6S259, and D6S285) used in previous linkage
reports on schizophrenia (Straub et al. 1995). PCR am-
plifications were performed in a reaction volume of 12
ml containing 40 ng of template DNA, 0.2 mM each of
dATP, dGTP, and dTTP, 1.25 mM dCTP, 25 nM 32P-a-
dCTP, 12 pmol of each primer, 50 mM KCl, 10 mM
Tris-HCl (pH 9.0), 0.1% Triton X-100, 1.5 mMMgCl2,
and 0.12 units of Taq DNA polymerase (Promega).
Thermocycling was conducted by use of a MJ Research
PTC-100 thermocycler, with an initial denaturation step
of 5 min at 93C; followed by 30 cycles of 1 min at
93C, 1 min at 55C, and 1 min at 72C; followed by
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Figure 1 Distribution of PANSS total scale scores for affected and unaffected subjects, under the narrow diagnostic classification of
schizophrenia. The numbers of affected subjects (gray-shaded bars) and unaffected subjects (unshaded bars), with values for each of the PANSS
scales, are presented for the (a) positive symptom–scale, (b) negative symptom–scale, and (c) GP symptom–scale scores of PANSS, which have
minimum possible values of 7, 7, and 16, respectively.
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a final extension step of 10 min at 72C. PCR products
were analyzed by electrophoresis on 6% nondenaturing
acrylamide gels and by subsequent autoradiography, at
room temperature, with Dupont Reflections film. All gels
included reference DNA samples (CEPH individuals
1331-01 and 1331-02) to allow comparative sizing. To
minimize the chance of errors due to sample mishan-
dling, all subject DNA samples were maintained in racks
of tubes compatible with standard 8#12 microtiter
plates. All subsequent stages of sample handling, from
PCR analysis through loading of the acrylamide gels,
were done by use of multichannel pipettes and syringes.
Scoring was performed by visual inspection by two
independent raters blind to subject phenotype. In the
case of discrepant allele interpretation, the autoradi-
ographs were reread by the two readers, and, if a dis-
crepancy remained, PCR and electrophoresis of the sam-
ples in question were repeated. Certain genotypes,
although being concordantly scored, nonetheless were
not consistent with Mendelian inheritance. For these
samples, the genotyping procedure was repeated, from
the PCR stage. In all cases in which the apparent non-
Mendelian inheritance persisted, it could be explained
by a one-repeat-unit change in size of the microsatellite
marker. Since the source of the original allele could not
always be determined, we consistently excluded from
our analysis any genotypes that exhibited evidence of
size instability.
Statistical Analyses
Parametric analyses were conducting by use of LINK-
AGE version 5.2 programs. Five models were analyzed,
two each for the narrow and broad diagnostic classifi-
cations and one for the very broad classification. Under
the narrow diagnostic classification, the dominantmodel
was schizophrenia susceptibility–allele frequency (PA)
.009 and disease penetrance (f) .75, .50, and .001 for
disease homozygotes (AA), heterozygotes (Aa), and nor-
mal homozygotes (aa), respectively; the recessive model
was , , , andP  .13 f(AA)  .50 f(Aa)  .0015 f(aa) A
. Under the broad diagnostic classification, the.0015
dominant model was , ,P  .014 f(AA)  .90 f(Aa) A
, and , and the recessive model was.80 f(aa)  .009
, , , and . TheP  .20 f(AA)  .60 f(Aa)  .01 f(aa)  .01A
very broad diagnostic classification was analyzed under
the intermediate “Pen” model of Straub et al. (1995),
with , , , andP  .035 f(AA)  .85 f(Aa)  .425 f(aa) A
. Two-point linkage analyses were conducted by.0108
use of MLINK, at recombination fraction (v) values of
0, .01, .05, .1, .2, .3, and .4. Heterogeneity testing was
conducted on these results by use of the HOMOG pro-
gram. Allele frequencies for the analysis were estimated
by use of a set of 25 unrelated subjects from these fam-
ilies. Since the distribution of PANSS scores in individ-
uals with presumably normal genotypes is unknown, we
were unable to construct a model to examine PANSS
scores as a quantitative trait by using a parametric
analysis.
Sib-pair analyses were conducted by use of the Ge-
netics Analysis System (GAS), version 2.0 (Young 1995).
The SIBHE and SIBIHE modules of GAS were used for
two-point and multipoint analyses, respectively. These
modules implement the Elston-Haseman algorithm for
an identity-by-descent analysis of quantitative traits
(Haseman and Elston 1972), which makes no assump-
tions about the underlying distribution of the quanti-
tative traits. This algorithm compares the square of the
difference in the value of the quantitative trait for all
sibling pairs, ranging from highly concordant to highly
discordant. Total scores on the positive-symptom, neg-
ative-symptom, and GP-symptom scales of the PANSS
were each used as quantitative traits for sib-pair analysis
with the 161 subjects on whom usable PANSS data were
available. The Elston-Haseman algorithm may also be
applied to the analysis of categorical data, by setting the
squared trait difference equal to 0 for concordant sib
pairs and equal to 1 for discordant sib pairs (Tran et al.
1995). In GAS, this is easily accomplished by coding
unaffected individuals with the value 0 and affected in-
dividuals with the value 1 and then running the standard
SIBHE and SIBIHE routines. Sib-pair analyses were thus
conducted under the categorical diagnostic classifica-
tions of narrow, broad, and very broad, described above.
Analyses were first conducted by use of categorical di-
agnostic data for all 183 subjects and then, for better
comparison with the quantitative-trait analysis, were re-
peated for the 22 individuals with unavailable or un-
usable PANSS data coded as phenotype unknown.
The SIBIHE module was used for sib-pair interval
mapping, with information from adjacent markers being
used to infer missing or ambiguous allele sharing. This
routine calculates the sharing probabilities in four steps.
First, the loci at which the sharing status is definitely
known are stored. Next, the estimated sharing at am-
biguous intercrosses is calculated. Unknown-sharing-
status loci are then interpolated from the results of the
first two steps, and, finally, interloci values are inter-
polated on the basis of the results of the first three steps.
Further details of these algorithms may be found in the
GAS 2.0 analysis modules manual (Young 1995).
For the Weber-screening-set markers, multipoint anal-
yses were conducted by use of v values from the CHLC’s
Weber V6 Screening Set Extended Map’s Recombina-
tion-Minimization Map Data (table 2), obtained from
the CHLC website (http://www.chlc.org). Since no single
map was available that integrated these markers with
the additional markers from chromosome 6p that were
genotyped, data from the additional markers were ex-
amined in a separate multipoint analysis using the fol-
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Table 1
Zmax for Two-Point Linkage Analysis of Schizophrenia, with
Chromosome 6 Markers
Genetic Model
and Diagnostic
Classification Marker Locus Zmax vmax
Dominant:
Narrow D6S477 .31 .3
Broad D6S1040 .14 .3
Recessive:
Narrow D6S1040 .77 .1
Broad D6S1003 1.19 .2
Pen:
Very broad D6S1040 .24 .2
lowing genetic map, presented by Straub et al. (1995):
D6S477–.061–D6S296–.007–D6S277–.019–D6S470–
.074–D6S259–.059–D6S285.
For all sib-pair analyses, the DFWEIGHT option was
used to compensate for multipair sibships. In the as-
sessment of the significance of the least-squares best-fit
line, N pairs in a sibship contribute ( ) df—insteadN 1
of N df, which is used when all data points are inde-
pendent. N and df were as follows: for two-point anal-
yses, 15–164 pairs and df 6–49, depending on the in-
formativeness of markers; for quantitative-trait
multipoint analyses using the PANSS scores, 324 pairs
and df 84 for the Weber V6 markers and 197 pairs and
df 59 for the additional 6p markers; and, for the cate-
gorical multipoint analyses using all subjects, 379 pairs
and df 98 for the Weber V6 markers and 235 pairs and
df 70 for the additional 6p markers.
To assess the empirical P value associated with the
nominal P values generated by the nonparametric anal-
yses, simulation studies were conducted by use of SIM-
ULATE (Terwilliger and Ott 1994), a software program
that will simulate genotypes in family members for a
map of linked markers that are unlinked to a given af-
fection-status locus. Since the program does not use af-
fection status–locus information for the generation of
marker data, it is easily modified to accept quantitative-
trait values instead. The simulation studies were con-
ducted to allow for the multiple testing involved in the
analysis of the multiple marker loci and the three quan-
titative and three categorical traits. Ten thousand un-
linked replicates of pedigree sets with the subjects’ orig-
inal PANSS and categorical affection-status data were
simulated, and each replicate was analyzed by use of the
same procedures as were used for the actual linkage data.
Each replicate was separately analyzed by use of the
quantitative and categorical phenotypes, with the most
significant P values from each set of two-point and mul-
tipoint analyses extracted and compiled into a single
distribution. This produced a total of four distributions:
one for the two-point analyses and one for the multi-
point analyses, for each of the categorical traits and the
quantitative traits. The smallest nominal P value from
the real analysis was then compared with these distri-
butions of 10,000 simulated P values, to determine how
often such a P value would be expected by chance in an
unlinked data set. This is reported as the empirical P
value. The smallest P value from the entire set of cor-
responding categorical-trait and quantitative-trait anal-
yses was also extracted and assembled into a single dis-
tribution, to allow for the determination of the empirical
significance of the single smallest nominal P value across
the entire set of six phenotypes.
Results
Under the diagnostic schemes tested, the parametric
analyses produced no significant evidence of linkage to
chromosome 6 in these families. Under the dominant,
the recessive, and the intermediate Pen model of Straub
et al. (1995), two-point analysis of 28 markers spanning
chromosome 6 produced no significant evidence for link-
age under the hypothesis of homogeneity (table 1). Anal-
ysis of these results by the HOMOG program produced
no significant evidence for heterogeneity: no odds ratio
favoring linkage under the hypothesis of heterogeneity
was 12.1.
Sib-pair analysis conducted with use of the narrow,
broad, and very broad diagnostic categories produced
no significant evidence for linkage, with either the two-
point approach or the multipoint approach. Results of
the multipoint sib-pair analyses using the Weber-screen-
ing-set chromosome 6 markers are presented in table 2.
Separate multipoint analyses with the 6p markers
D6S477, D6S296, D6S277, D6S470, D6S259, and
D6S285, used in other schizophrenia linkage studies, are
presented in table 3. The smallest nominal P values were
.0096 for the two-point analysis and .038 for the mul-
tipoint analysis, in both cases with marker D6S1009 and
the very broad diagnostic classification. These corre-
spond to empirical P values of .35 and .42, respectively.
To allow better comparability with the analyses using
the PANSS ratings, these analyses were also conducted
with any subjects lacking PANSS data coded as cate-
gorical phenotype unknown. The removal of the phe-
notype data on these 22 subjects did not significantly
alter any results.
In contrast, both the two-point and multipoint sib-
pair analyses using the PANSS scale scores as quanti-
tative traits produced significant evidence (empirical
) for linkage. The results for the two-point andP ! .05
multipoint analyses were similar. The two-point analysis
produced significant evidence (nominal P  1.2#
, empirical ) for linkage to marker locus510 P  .034
D6S1960, for the positive symptom–scale score only.
The multipoint analysis produced significant evidence
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Table 2
Results of Multipoint Sib-Pair Analysis Using Categorical Diagnostic Definitions and PANSS Scale Scores and Chromosome 6 Markers
(Weber V6 Screening Set)
INTERMARKER va LOCUSb
NOMINAL P
Categorical Traits Quantitative Traits
Narrow Broad Very Broad Positive Symptoms Negative Symptoms GP Symptoms
.04 D6S477 .049 .54 .48 .52 .0060 .11
.11 D6S263 .34 .58 .64 .42 .048 .052
.17 D6S1006 .64 .58 .50 .31 .017 .020
.06 D6S1050 .55 .52 .42 .092 .028 .020
.10 D6S1281 .65 .63 .50 .13 .070 .047
.06 D6S1019 .66 .57 .39 .062 .16 .23
.14 D6S1017 .84 .77 .60 .062 .25 .13
.04 D6S1280 .91 .77 .79 .000030 .17 .0088
.04 D6S1960 .83 .59 .60 .0000054 c .071 .00032
.06 D6S1053 .78 .61 .59 .000070 .061 .0037
.06 D6S1031 .90 .78 .74 .00030 .14 .0070
.11 D6S1270 .93 .82 .74 .00062 .15 .010
.10 D6S1056 .93 .84 .69 .017 .17 .036
.06 D6S1021 .91 .71 .57 .059 .076 .038
.10 D6S474 .93 .54 .39 .11 .082 .049
.01 D6S1040 .91 .21 .11 .21 .18 .018
.08 D6S1009 .93 .099 .038 .39 .14 .12
.14 D6S1003 .97 .29 .23 .53 .34 .25
.07 D6S1007 .96 .77 .75 .47 .74 .29
.07 D6S305 .99 .76 .88 .49 .79 .32
.12 D6S1277 .97 .83 .89 .63 .81 .51
.03 D6S503 .98 .99 .99 .57 .75 .39
D6S1027 .98 .98 .99 .56 .78 .41
a Between each contiguous pair of loci shown.
b Arranged from most telomeric on 6p (D6S477) to most telomeric on 6q (D6S1027).
c Significant at empirical .P  .0085
Table 3
Results of Multipoint Sib-Pair Analysis Using Categorical Diagnostic Definitions and PANSS Scale Scores and Chromosome 6p Markers
Used in Previous Studies
INTERMARKER va LOCUSb
NOMINAL P
Categorical Traits Quantitative Traits
Narrow Broad Very Broad Positive Symptoms Negative Symptoms GP Symptoms
.061 D6S477 .10 .69 .62 .13 .0018 .036
.007 D6S296 .72 .83 .86 .021 .029 .0024
.019 D6S277 .50 .67 .72 .018 .033 .0021
.074 D6S470 .71 .83 .87 .012 .045 .0017
.059 D6S259 .83 .86 .75 .0080 .077 .0056
D6S285 .82 .84 .78 .026 .14 .030
a Between each contiguous pair of loci shown.
b Arranged from most telomeric (D6S477) to most telomeric (D6S285) on 6p.
for linkage (nominal , empirical6P  5.4# 10 P 
) to D6S1960, again only for the positive symp-.0085
tom–scale score. When all sib-pair analyses, quantitative
and categorical, are considered together, this multipoint
linkage result corresponds to a P value of .011. Results
of the multipoint sib-pair analyses using the Weber-
screening-set chromosome 6 markers are presented in
table 2; and the results of the multipoint analyses with
the additional chromosome 6p markers are presented in
table 3. Although none of the empirical P values from
the analyses of the 6p markers were significant, most of
the nominal P values were !.05.
Discussion
To date, individual linkage studies of schizophrenia
have produced mixed results, characterized by sugges-
tive, but not significant, results and frequent lack of rep-
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lication across studies. The finding of potential linkage
to chromosome 6p has been the most reproducible of
these findings, yielding suggestive or marginally signif-
icant results in several large samples (Moises et al. 1995;
Schwab et al. 1995; Straub et al. 1995). Although dif-
ferent diagnostic and analytic approaches have been
used, all of these studies share the basic methodology of
assigning subjects to clinically derived categorical defi-
nitions of illness, which may not be as powerful as link-
age analyses using quantitative traits. Our results suggest
that using selected quantitative behavioral traits may
provide significantly increased power in linkage studies
of schizophrenia.
Our initial parametric and nonparametric analyses us-
ing categorical diagnoses failed to produce any signifi-
cant evidence of linkage to chromosome 6, despite using
a sample of ethnic origin similar to that studied by
Straub et al. (1995). To make our study as comparable
as possible to the findings of Straub et al. (1995), we
included a parametric analysis using the same diagnostic
classification and inheritance model as was used for the
maximum LOD score (Zmax) obtained in their study. Al-
though we failed to find significant evidence for linkage
with this genetic model, it must be noted that our sample
is only 12% of the size of the sample studied by Straub
et al. (1995). Given that their Zmax was 3.51, with an
estimated 60% of families unlinked, it would not be
surprising for our sample of 10 families to be too small
to either detect linkage or statistically support the hy-
pothesis of heterogeneity. Additionally, although our
sample has many sibling pairs, because of the distribu-
tion of affected individuals, there are relatively few pairs
of affected siblings, with a maximum of 75 affected sib
pairs, under the very broad diagnostic classification. Be-
cause of this, we chose to employ the Elston-Haseman
algorithm to analyze our categorical sib-pair data, thus
utilizing affected, unaffected, and discordant pairs.
However, it should be noted that this analysis is not
directly comparable to the chromosome 6 affected-sib-
pair analyses reported by other groups.
The use of positive- and negative-symptom scores as
quantitative traits introduces into the analysis two
changes that may increase the power to detect linkage.
First, the use of a quantitative instead of categorical trait
is associated with increased power in linkage analysis.
Second, the assessment of symptom clusters captures
phenotypic elements different than those described by
categorical diagnoses. The specificity of the significant
linkage results to the positive-symptom scores but not
to the negative-symptom scores suggests that the power
increase found in our study may represent more than
just the generally increased power of quantitative-trait
analyses. Positive- and negative- symptom clusters ap-
pear to be partially overlapping dimensions of a schizo-
phrenia phenotype in families and may have different
susceptibility loci (Bassett et al. 1993). With regard to
schizophrenia, positive symptoms may be more strongly
correlated with an underlying genetic vulnerability lo-
cated on chromosome 6p than are negative symptoms.
Alternatively, negative symptoms related to a schizo-
phrenia locus may be more susceptible to noise from
unrelated disorders such as alcoholism in schizophrenia
families (Bassett et al. 1993), with linkage thereby ob-
scured. Further studies are needed to resolve these issues.
Another important contrast between the current study
and previously published nonparametric analyses of
schizophrenia is the use of simulation studies to evaluate
the nominal P values generated by the analysis pro-
grams. Many sib-pair analyses of schizophrenia have
previously interpreted nominal P values of !.05 as being
significant. Lander and Krugylak (1995) recently sug-
gested guidelines for P values that should be taken as
significant for genomewide linkage studies in sib-pair
analysis, with offered as the threshold5P  2.2# 10
for a significant finding and with as the4P  7.4# 10
threshold for suggestive findings. Although these guide-
lines are certainly helpful, they do not take into account
the effects of all the variables that may be acting in a
particular study. In the current study we determined em-
pirical P values from the distribution of nominal P values
generated by the analysis of a series of unlinked, sim-
ulated data sets. In doing so, we have corrected for the
multiple testing associated with both genotyping a dense
genetic map and using multiple diagnostic models. This
method thereby produces a better estimate of the chances
that the finding represents a false-positive linkage.
The markers demonstrating significant linkage to pos-
itive-symptom scores in this study are centered around
the 6p11-p21 region, slightly more centromeric to the
6p24-21 region previously implicated in schizophrenia
(Moises et al. 1995; Schwab et al. 1995; Straub et al.
1995; Wang et al. 1995). Several explanations for these
slightly different localizations are possible. First, two dis-
tinct loci contributing to schizophrenia vulnerability
could be located on chromosome 6. Second, the differ-
ences in phenotypic classification may be producing im-
precision in susceptibility-locus localization. Finally,
most of the markers used in this and previous studies
were different, with many of the cited studies not re-
porting results on markers extending into the p11 region
of chromosome 6, the area of our most significant link-
age finding. Also of note is that, although none of the
more distal 6p markers used provided significant evi-
dence for linkage when empirical P values were consid-
ered, many of the nominal P values for linkage of the
PANSS scale scores to these markers were !.05 and
therefore would likely have been reported as significant
according to methodology used in prior studies. This
result further underlines the value of using simulation
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or other statistical methods to determine the true sig-
nificance associated with linkage-analysis results.
Schizophrenia is a complex disorder, with unclear in-
heritance and evidence for multiple components to the
clinical phenotype. Previous linkage studies of markers
from chromosome 6p, using diagnostic categories as
phenotypes, have resulted in suggestive or marginally
significant findings in samples of 358–1,408 individuals
(Moises et al. 1995; Schwab et al. 1995; Straub et al.
1995). Although the validity of a quantitative-trait ap-
proach to schizophrenia has not yet been proved, we
have been able to identify a significant linkage finding
with a sample of only 183 subjects, by performing a
quantitative-trait analysis using certain component fea-
tures of the schizophrenia phenotype. The use of the
three scales of the PANSS represents a relatively straight-
forward approach to examination of different aspects of
schizophrenia. Additional refinement of the components
of the schizophrenia phenotype will allow for further
increases in power and accuracy in linkage studies of
this challenging disorder.
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